GPCR

Structure Therapeutics Inc.

62.01 USD
+0.14 (+0.23%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Structure Therapeutics Inc. stock is up 9.42% since 30 days ago. The next earnings date is Feb 14, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 1 December’s closed higher than November. 100% of analysts rate it a buy.

About Structure Therapeutics Inc.

We are a clinical stage global biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. We are a Cayman Islands exempted company incorporated with limited liability. We were initially formed as a Delaware corporation in 2016 under the name ShouTi Inc., and reorganized as a Cayman Islands exempted company in 2019. Our principal executive office is located at 611 Gateway Blvd., Suite 223, South San Francisco, California. The principal executive office of our research and development operations is located at Unit 02, F5, No. 1, Lane 2889, Jinke Road, China (Shanghai) Free Trade Zone, Shanghai, People’s Republic of China, 201203. Our telephone number at this address is 86 21 61215839. Our current registered office in the Cayman Islands is located at the offices of International Corporation Services Ltd., P.O, Box 472, 2nd Floor, Harbour Place, 103 South Church Street, George Town, Grand Cayman.

  • JP Morgan
    Mon Nov 20, 09:15
    buy
    confirm
  • JP Morgan
    Wed Nov 15, 12:48
    buy
    confirm